Enovis Corporation Overview
Pro stress-test →Enovis Corporation is a medical technology company with a focus in orthopedics. The company offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. The company serves a broad market addressing musculoskeletal health, joint reconstruction, vascular health, and pain management.
Strategic Profile
Pro stress-test →After a major spin-off in April 2022 that separated its industrial ESAB business, the company completed its transformation into a pure-play medical technology company. In September 2023, Enovis announced a definitive agreement to acquire LimaCorporate for approximately €800 million, which strengthens its reconstructive orthopedics portfolio. The company operates through two segments: Prevention and Recovery (consumer-focused products) and Reconstructive (surgical solutions).
Competitive Landscape
Pro stress-test →Zimmer Biomet is a major competitor in the orthopedic space. Enovis competes in the fragmented orthopedic market against larger players like Zimmer Biomet, Stryker, and Johnson & Johnson's orthopedic divisions. The company differentiates through its comprehensive coverage across the full patient care continuum and strong brand recognition in specialty segments like bracing and rehabilitation.
Industry Context
Enovis Corporation operates in Orthopedic Medical Devices & Rehabilitation Technology.
Key facts
Founded: 1995 · Headquarters: Wilmington, Delaware · Employees: 8000+ · Revenue: $2.25B · Market cap: $1.46B